Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Molecular Medicine Reports|September 6, 2012
Abnormal function of monoamine oxidase-A in comorbid major depressive disorder and cardiovascular disease: pathophysiological and therapeutic implications (review)Rodrigo Machado-Vieira, Alan G MallingerPsychopharmacology Bulletin|November 11, 2003
Effects of tranylcypromine on the sleep of patients with anergic bipolar depressionRipu D Jindal, Amy L Fasiczka, Jonathan M Himmelhoch, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2011
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depressionLobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, et al.Journal of Affective Disorders|March 23, 2013
Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot studyJose A Franco-Chaves, Camilo F Mateus, David A Luckenbaugh, et al.Psychopharmacology Bulletin|July 25, 2009
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?Alan G Mallinger, Ellen Frank, Michael E Thase, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2004
1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administrationPaolo Brambilla, Jeffrey A Stanley, Roberto B Sassi, et al.Bipolar Disorders|April 14, 2007
Context processing performance in bipolar disorder patientsPaolo Brambilla, Angus W Macdonald, Roberto B Sassi, et al.The American Journal of Psychiatry|January 5, 2002
Slower treatment response in bipolar depression predicted by lower pretreatment thyroid functionDaniel P Cole, Michael E Thase, Alan G Mallinger, et al.Neuroscience Letters|August 8, 2002
Increased gray matter volume in lithium-treated bipolar disorder patientsRoberto B Sassi, Mark Nicoletti, Paolo Brambilla, et al.Bipolar Disorders|July 15, 2009
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanismsAlan G Mallinger, Michael E Thase, Roger Haskett, et al.Pageof 4